Cargando…
Live-attenuated YF17D-vectored COVID-19 vaccine protects from lethal yellow fever virus infection in mouse and hamster models
BACKGROUND: The live-attenuated yellow fever vaccine YF17D holds great promise as alternative viral vector vaccine platform, showcased by our previously presented potent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine candidate YF-S0. Besides protection from SARS-CoV-2, YF-S0 al...
Autores principales: | Ma, Ji, Yakass, Michael Bright, Jansen, Sander, Malengier-Devlies, Bert, Van Looveren, Dominique, Sanchez-Felipe, Lorena, Vercruysse, Thomas, Weynand, Birgit, Javarappa, Mahadesh Prasad Arkalagud, Quaye, Osbourne, Matthys, Patrick, Roskams, Tania, Neyts, Johan, Thibaut, Hendrik Jan, Dallmeier, Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9419561/ https://www.ncbi.nlm.nih.gov/pubmed/36041265 http://dx.doi.org/10.1016/j.ebiom.2022.104240 |
Ejemplares similares
-
YF17D-vectored Ebola vaccine candidate protects mice against lethal surrogate Ebola and yellow fever virus challenge
por: Lemmens, Viktor, et al.
Publicado: (2023) -
Yellow Fever Virus Down-Regulates mRNA Expression of SOCS1 in the Initial Phase of Infection in Human Cell Lines
por: Yakass, Michael B., et al.
Publicado: (2020) -
Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
por: Li, Li-Hsin, et al.
Publicado: (2022) -
MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022) -
Updated vaccine protects against SARS-CoV-2 variants including Omicron (B.1.1.529) and prevents transmission in hamsters
por: Sharma, Sapna, et al.
Publicado: (2022)